ZINFORO

This brand name is authorized in Austria, Brazil, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United Kingdom, South Africa

Active ingredients

The drug ZINFORO contains one active pharmaceutical ingredient (API):

1 Ceftaroline fosamil acetic acid solvate monohydrate UNII P9VXV1408Y - CEFTAROLINE FOSAMIL ACETATE

In vitro studies have shown that ceftaroline is bactericidal and able to inhibit bacterial cell wall synthesis in methicillin-resistant Staphylococcus aureus (MRSA) and penicillin non-susceptible Streptococcus pneumoniae (PNSP) due to its affinity for the altered penicillin-binding proteins (PBPs) found in these organisms. As a result, minimum inhibitory concentrations (MICs) of ceftaroline against a proportion of these organisms tested fall into the susceptible range. Read about Ceftaroline fosamil

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZINFORO Powder for concentrate for solution	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DI02		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DI Other cephalosporins
Discover more medicines within J01DI02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502314080023402, 522718010070017
Country: EE	Ravimiamet	Identifier(s): 1592962
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 12785001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 491567
Country: FR	Base de données publique des médicaments	Identifier(s): 65424751
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 213872
Country: HK	Department of Health Drug Office	Identifier(s): 62093
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7994
Country: IT	Agenzia del Farmaco	Identifier(s): 042352017
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1067337
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 103012
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15706
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100284394
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63724001
Country: SG	Health Sciences Authority	Identifier(s): 14268P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 14433011H
Country: ZA	Health Products Regulatory Authority	Identifier(s): 46/20.1.1/0628